Low-coverage whole-sequencing of metastasised colorectal cancer samples treated with bevazicumab
Low-coverage whole-genome sequencing (LC-WGS) was performed on tumor tissue, normal tissue and plasma samples collected from mCRC patients from the AC-ANGIOPREDICT Phase II trial (NCT01822444) and the University Medical Center Mannheim (UMM).
- Type: Whole Genome Sequencing
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD50000000176 | Illumina HiSeq 4000 | 164 |
Publications | Citations |
---|---|
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients.
NPJ Genom Med 9: 2024 33 |
0 |